Trandolapril and Verapamil Hydrochloride
- Product NDC
- 59762-0142
- 11-digit product format
- 597620142
- Labeler code
- 59762
- Product ID
- 59762-0142_35f39159-66fa-d915-af29-b37d8f5a7800
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Trandolapril and Verapamil Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Greenstone LLC
- Application
- NDA020591
- Marketing category
- NDA
- Marketing start
- 2015-02-25
- Marketing end
- 2021-08-14
- Substance
- TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
- Active strength
- 2 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59762-0142-1 | 59762014201 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59762-0142-1) | 2015-02-25 | 2021-08-14 | No | No | Current |